Ranitidine
- Product NDC
- 43353-967
- 11-digit product format
- 433530967
- Labeler code
- 43353
- Product ID
- 43353-967_16943070-3f5f-49a0-a295-ad86344976b6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranitidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA077824
- Marketing category
- ANDA
- Marketing start
- 2014-08-18
- Marketing end
- 0000-00-00
- Substance
- RANITIDINE HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43353-967-60 | Ranitidine | 90 in 1 BOTTLE | TABLET | 90 | | 2 |
| 43353-967-80 | Ranitidine | 180 in 1 BOTTLE | TABLET | 180 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-967 | RANITIDINE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | Legacy NDC, 2 package rows | 20191231_7f3348a9-ce69-48d6-89f4-5c0e7d38a255.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-967-60 | 43353096760 | 90 TABLET in 1 BOTTLE (43353-967-60) | 90 tablet | 2014-10-10 | 0000-00-00 | No | No | Current |
| 43353-967-80 | 43353096780 | 180 TABLET in 1 BOTTLE (43353-967-80) | 180 tablet | 2014-10-01 | 0000-00-00 | No | No | Current |